How to buy Soligenix stock

Soligenix, Inc is a biotechnology business based in the US. Soligenix shares (SNGX) are listed on the NASDAQ and all prices are listed in US Dollars. Soligenix employs 17 staff and has a trailing 12-month revenue of around 0.00.

Soligenix share price

Use our graph to track the performance of SNGX stocks over time.

Soligenix shares at a glance

• Key figures

Information last updated 2021-04-23.

52-week range	$1.21 - $2.99
50-day moving average	$1.56
200-day moving average	$1.75
Wall St. target price	$4.06
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.49

Buy Soligenix shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Soligenix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Soligenix, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Soligenix financials

Revenue TTM	$2.4 million
Gross profit TTM	$538,498
Return on assets TTM	-83.98%
Return on equity TTM	-680.46%
Profit margin	0%
Book value	$0.12
Market capitalisation	$55.6 million

TTM: trailing 12 months

Shorting Soligenix shares

There are currently 1.7 million Soligenix shares held short by investors – that's known as Soligenix's "short interest". This figure is 7.3% down from 1.8 million last month.

There are a few different ways that this level of interest in shorting Soligenix shares can be evaluated.

Soligenix's "short interest ratio" (SIR)

Soligenix's "short interest ratio" (SIR) is the quantity of Soligenix shares currently shorted divided by the average quantity of Soligenix shares traded daily (recently around 2.8 million). Soligenix's SIR currently stands at 0.6. In other words for every 100,000 Soligenix shares traded daily on the market, roughly 600 shares are currently held short.

However Soligenix's short interest can also be evaluated against the total number of Soligenix shares, or, against the total number of tradable Soligenix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Soligenix's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Soligenix shares in existence, roughly 40 shares are currently held short) or 0.0423% of the tradable shares (for every 100,000 tradable Soligenix shares, roughly 42 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Soligenix.

Find out more about how you can short Soligenix stock.

Soligenix share dividends

We're not expecting Soligenix to pay a dividend over the next 12 months.

Have Soligenix's shares ever split?

Soligenix's shares were split on a 1:10 basis on 6 October 2016. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Soligenix shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Soligenix shares which in turn could have impacted Soligenix's share price.

Soligenix share price volatility

Over the last 12 months, Soligenix's shares have ranged in value from as little as $1.21 up to $2.99. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Soligenix's is 1.3343. This would suggest that Soligenix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Soligenix overview

Soligenix, Inc. , a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301, a novel photodynamic therapy, which has completed Phase III clinical trial to treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial to treat oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipropionate, which has completed Phase I/II clinical trial for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including SGX203 for pediatric Crohn's disease and SGX201 for acute radiation enteritis. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia and Ib clinical trials; SGX943, a melioidosis therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate in pre-clinical development for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc.

Frequently asked questions

What percentage of Soligenix is owned by insiders or institutions?
Currently 2.874% of Soligenix shares are held by insiders and 9.294% by institutions. How many people work for Soligenix?
Latest data suggests 17 work at Soligenix. When does the fiscal year end for Soligenix?
Soligenix's fiscal year ends in December. Where is Soligenix based?
Soligenix's address is: 29 Emmons Drive, Princeton, NJ, United States, 08540 What is Soligenix's ISIN number?
Soligenix's international securities identification number is: US8342233074 What is Soligenix's CUSIP number?
Soligenix's Committee on Uniform Securities Identification Procedures number is: 258094101